Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.915 USD | +3.87% | +4.76% | -6.04% |
04-02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
04-02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.04% | 414M | |
+2.72% | 42.75B | |
+47.70% | 41.61B | |
+11.92% | 41.34B | |
-8.83% | 26.59B | |
+7.72% | 25.49B | |
-22.52% | 18.12B | |
+30.96% | 12.24B | |
-1.73% | 11.76B | |
+9.46% | 11B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Wedbush Adjusts Voyager Therapeutics Price Target to $4 From $3, Maintains Neutral Rating